A. Moorman

发表

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

J. Chmiel, K. Lichtenstein, C. Armon, 2008, Journal of acquired immune deficiency syndromes.

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

G. Satten, A. Moorman, S. Holmberg, 1998, The New England journal of medicine.

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.

A. Moorman, S. Holmberg, J. Boscarino, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak.

A. Moorman, J. Xing, Z. Moore, 2012, Vaccine.

Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series

P. Patel, A. Moorman, Y. Khudyakov, 2019, Kidney medicine.

Hepatitis C Virus Potentially Transmitted by Opioid Drug Diversion from a Nurse — Washington, August 2017–March 2018

C. Wasserman, A. Moorman, P. Montgomery, 2019, MMWR. Morbidity and mortality weekly report.

Nonhospital Health CareAssociated Hepatitis B and C Virus Transmission: United States, 19982008

A. Moorman, S. Holmberg, J. Perz, 2009, Annals of Internal Medicine.

The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA

D. Holtzman, A. Moorman, S. Mehta, 2019, Hepatology.

Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders.

A. Moorman, J. Boscarino, E. Henkle, 2014, The American journal of managed care.

The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy

H. Masur, A. Moorman, J. Grubb, 2006, AIDS.

Sustained virological response does not improve long‐term glycaemic control in patients with type 2 diabetes and chronic hepatitis C

A. Moorman, S. Holmberg, J. Boscarino, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015

A. Moorman, S. Holmberg, J. Xing, 2017, Journal of clinical gastroenterology.

Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study

A. Moorman, S. Holmberg, J. Boscarino, 2015, The American Journal of Gastroenterology.

Factors associated with chronic renal failure in HIV-infected ambulatory patients

G. Mcgwin, A. Moorman, S. Holmberg, 2004, AIDS.

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

J. Chmiel, K. Buchacz, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020

K. Buchacz, A. Moorman, J. Brooks, 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010.

A. Moorman, S. Holmberg, J. Boscarino, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

A. Moorman, S. Holmberg, M. Denniston, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C in the United States.

A. Moorman, S. Holmberg, M. Denniston, 2013, The New England journal of medicine.

Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006–2013

A. Moorman, S. Holmberg, J. Xing, 2016, Alimentary pharmacology & therapeutics.

Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.

A. Moorman, S. Holmberg, J. Xing, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reported reasons for testing among hepatitis B virus‐infected patients – Chronic Hepatitis Cohort Study (CHeCS), United States, 2006–2010

A. Moorman, S. Holmberg, Fujie Xu, 2014, Liver international : official journal of the International Association for the Study of the Liver.

A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C

A. Moorman, S. Holmberg, J. Xing, 2017, Digestive Diseases and Sciences.

HEPATITIS C VIRUS (HCV) PATIENTS IN A LARGE U.S. COHORT

A. Moorman, S. Holmberg, J. Boscarino, 2013 .

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

A. Moorman, S. Holmberg, J. Boscarino, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.

J. Ward, A. Moorman, S. Holmberg, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The persistence of underreporting of hepatitis C as an underlying or contributing cause of death, 2011-2017.

Yuna Zhong, A. Moorman, J. Boscarino, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher all‐cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006–2013

A. Moorman, S. Holmberg, J. Xing, 2016, Journal of viral hepatitis.

Health Insurance Status of Adults with Hepatitis in the United States: Implications of Results from the National Health Interview Survey, 2013-2018.

A. Moorman, K. Ly, Greta Kilmer, 2021, Population health management.

Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)

Kuan-Han H Wu, Yuna Zhong, A. Moorman, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunities.

A. Moorman, J. Xing, J. Boscarino, 2019, The American journal of managed care.

Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention

A. Moorman, S. Holmberg, J. Xing, 2015, Hepatology.

Outbreak of Hepatitis B Virus Infections Associated with Assisted Monitoring of Blood Glucose in an Assisted Living Facility–Virginia, 2010

P. Patel, A. Moorman, Y. Khudyakov, 2012, PloS one.

Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022.

K. Buchacz, A. Moorman, J. Brooks, 2022, MMWR. Morbidity and mortality weekly report.

Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus.

Noele P. Nelson, A. Moorman, J. Xing, 2018, Gastroenterology.

Transmission of Hepatitis A Virus through Combined Liver–Small Intestine–Pancreas Transplantation

Michael S. Green, Noele P. Nelson, A. Moorman, 2017, Emerging infectious diseases.

Remote Infection Control Assessments of US Nursing Homes During the COVID-19 Pandemic, April to June 2020

L. Epstein, A. Moorman, A. Kallen, 2022, Journal of the American Medical Directors Association.

Completeness of Reporting of Chronic Hepatitis B and C Virus Infections — Michigan, 1995–2008

A. Moorman, S. Holmberg, M. Klevens, 2013, MMWR. Morbidity and mortality weekly report.

Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012.

A. Moorman, S. Kamili, Jan Drobenuic, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)

A. Moorman, S. Holmberg, J. Boscarino, 2016, Digestive Diseases and Sciences.

Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors

A. Moorman, J. Brooks, S. Basavaraju, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hepatitis B Reverse Seroconversion and Transmission in a Hemodialysis Center: A Public Health Investigation and Case Report.

P. Patel, A. Moorman, J. Brooks, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014‐2017

A. Moorman, S. Ramachandran, S. Basavaraju, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Notes from the Field: Hepatitis C Transmission from Inappropriate Reuse of Saline Flush Syringes for Multiple Patients in an Acute Care General Hospital — Texas, 2015

A. Moorman, G. Vaughan, S. Melville, 2017, MMWR. Morbidity and mortality weekly report.

Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing

K. O'Laughlin, J. Tate, J. D. da Silva, 2021, Emerging infectious diseases.

APRI and FIB‐4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)

A. Moorman, S. Holmberg, J. Boscarino, 2014, Journal of viral hepatitis.

Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.

K. Buchacz, A. Moorman, K. Wood, 2009, AIDS patient care and STDs.

Unexpected Hepatitis B Virus Infection After Liver Transplantation — United States, 2014–2019

A. Moorman, S. Basavaraju, S. Kamili, 2021, MMWR. Morbidity and mortality weekly report.

Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure

Yuna Zhong, A. Moorman, J. Boscarino, 2020, Hepatology communications.

Transmission of SARS-CoV-2 from Children and Adolescents

C. Szablewski, C. Drenzek, J. Tate, 2020, medRxiv.

Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

John T Brooks, J. Chmiel, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.

D. Ward, A. Moorman, S. Holmberg, 1998, JAMA.

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

P. Sullivan, A. Moorman, S. Holmberg, 2008, Annals of internal medicine.

Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

C. Armon, A. Moorman, K. Wood, 2006, AIDS patient care and STDs.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

A. Moorman, K. Wood, S. Holmberg, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016)

A. Moorman, J. Boscarino, S. Trudeau, 2021, Journal of clinical gastroenterology.

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

P. Rhodes, D. Ward, K. Lichtenstein, 2001, AIDS.

Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).

J. Ward, A. Moorman, J. Xing, 2011, MMWR. Morbidity and mortality weekly report.

Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007 †

K. Buchacz, A. Moorman, J. Brooks, 2010, Journal of viral hepatitis.

Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009.

P. Patel, B. Gooch, A. Moorman, 2013, Journal of the American Dental Association.

Acute Hepatitis B Outbreaks in 2 Skilled Nursing Facilities and Possible Sources of Transmission: North Carolina, 2009–2010

James Colborn, Yury Khudyakov, A. Moorman, 2013, Infection Control & Hospital Epidemiology.

Unexpected hepatitis B virus infection after liver transplantation — United States, 2014–2019

A. Moorman, S. Basavaraju, S. Kamili, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Association of HIV Susceptibility Testing With Survival Among HIV-Infected Patients Receiving Antiretroviral Therapy: A Cohort Study

S. Cole, J. Chmiel, C. Armon, 2009, Annals of Internal Medicine.

Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010.

A. Moorman, J. Xing, S. Kamili, 2014, Vaccine.

Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007

L. Finelli, B. Bell, K. Buchacz, 2010, Journal of acquired immune deficiency syndromes.

Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients

K. Buchacz, A. Moorman, K. Wood, 2006, Journal of acquired immune deficiency syndromes.

How many pills do patients with HIV infection take?

A. Moorman, S. Holmberg, J. V. Von Bargen, 1998, JAMA.

Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010.

Loralee Rupp, Xin Tong, Fujie Xu, 2015, Journal of hepatology.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

J. Ward, K. Buchacz, A. Moorman, 2011, Journal of viral hepatitis.

Transmission of blood-borne pathogens in US dental health care settings: 2016 update.

Shellie Kolavic Gray, B. Gooch, V. Robison, 2016, Journal of the American Dental Association.

Renal Function in Tenofovir-Exposed and Tenofovir-Unexposed Patients Receiving Highly Active Antiretroviral Therapy in the HIV Outpatient Study

J. Chmiel, K. Buchacz, A. Moorman, 2007, Journal of the International Association of Physicians in AIDS Care.

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

Maria Deloria-Knoll, Alan Greenberg, Scott Holmberg, 2003, Annals of Internal Medicine.

Influence of Human Immunodeficiency Virus Infection on Pelvic Inflammatory Disease

D. Schwartz, A. Moorman, R. Byers, 2000, Obstetrics and gynecology.

Adjuvant ribavirin and longer direct‐acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure

Kuan-Han H Wu, A. Moorman, J. Boscarino, 2019, Journal of viral hepatitis.

Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance

Reena Mahajan, Anne C. Moorman, Stephen J. Liu, 2013, J. Am. Medical Informatics Assoc..

Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.

A. Moorman, S. Holmberg, J. Xing, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Discontinuation of Chemoprophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection

A. Moorman, S. Holmberg, B. Yangco, 2000, Annals of Internal Medicine.

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

J. Chmiel, A. Moorman, S. Holmberg, 2002, AIDS.

Factors associated with maintenance of long-term plasma human immunodeficiency virus RNA suppression.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005

K. Buchacz, A. Moorman, K. Wood, 2008, AIDS.

Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients

A. Moorman, S. Holmberg, F. Palella, 1998 .

Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses — United States, 2010–2017

A. Moorman, J. Brooks, S. Basavaraju, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses — United States, 2010–2017

A. Moorman, J. Brooks, S. Basavaraju, 2019, MMWR. Morbidity and mortality weekly report.

Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020

A. Moorman, D. Henderson, S. Gordon, 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

John M Williamson, R. Janssen, D. Ward, 2002, The Lancet.

Incidence of and Risk Factors for Lipoatrophy (Abnormal Fat Loss) in Ambulatory HIV-1-Infected Patients

D. Ward, K. Lichtenstein, C. Armon, 2003, Journal of acquired immune deficiency syndromes.

A 7-year longitudinal analysis of IL-2 in patients treated with highly active antiretroviral therapy.

K. Lichtenstein, C. Armon, A. Moorman, 2004, AIDS.

Notes from the Field: HIV Outbreak During the COVID-19 Pandemic Among Persons Who Inject Drugs — Kanawha County, West Virginia, 2019–2021

A. Moorman, A. Oster, Molly Deutsch-Feldman, 2022, MMWR. Morbidity and mortality weekly report.

Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS).

D. Ward, A. Moorman, S. Holmberg, 1999, Annals of epidemiology.

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

K. Lichtenstein, C. Armon, A. Moorman, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with the successful modification of antiretroviral therapy

K. Lichtenstein, A. Moorman, S. Holmberg, 2000 .

Hepatitis C virus: an overview for dental health care providers.

A. Moorman, R. Klevens, Dr. R. Monina Klevens, 2013, Journal of the American Dental Association.

Locations and Reasons for Initial Testing for Hepatitis C Infection — Chronic Hepatitis Cohort Study, United States, 2006–2010

A. Moorman, S. Holmberg, J. Boscarino, 2013, MMWR. Morbidity and mortality weekly report.

All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus.

Robert E. Smith, A. Moorman, S. Holmberg, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mental and physical health status among chronic hepatitis B patients

A. Moorman, J. Boscarino, S. Gordon, 2020, Quality of Life Research.

Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings.

Yuna Zhong, A. Moorman, S. Holmberg, 2018, Infectious disease clinics of North America.

Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS)

A. Moorman, S. Holmberg, J. Boscarino, 2015, Hepatology.

Investigation of viral hepatitis infections possibly associated with health-care delivery--New York City, 2008-2011.

Madison, Atlanta, T. Frieden, 2012, MMWR. Morbidity and mortality weekly report.

Investigation of Hepatitis B Virus and Human Immunodeficiency Virus Transmission among Severely Mentally Ill Residents at a Long Term Care Facility

W. Heneine, P. Peters, A. Moorman, 2012, PloS one.

Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study

A. Moorman, S. Holmberg, J. Xing, 2016, Digestive Diseases and Sciences.

Detection, Reporting, and Treatment of Hepatitis C Infections Among Hemodialysis Patients

P. Patel, A. Moorman, D. Nguyen, 2017, Infection Control & Hospital Epidemiology.

Notes from the Field: Health Care-Associated Hepatitis A Outbreak - Texas, 2015.

A. Moorman, Y. Khudyakov, T. Mixson-Hayden, 2016, MMWR. Morbidity and mortality weekly report.

Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006–2015

A. Moorman, S. Holmberg, J. Boscarino, 2019, Open forum infectious diseases.

Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis

A. Moorman, S. Holmberg, J. Boscarino, 2019, Journal of Gastrointestinal Cancer.

Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma

A. Moorman, S. Holmberg, J. Boscarino, 2016, Journal of viral hepatitis.

Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

D. Ward, A. Moorman, K. Wood, 2002, AIDS.

Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States

Yuna Zhong, A. Moorman, S. Holmberg, 2018, Journal of viral hepatitis.

Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes

A. Moorman, S. Holmberg, J. Boscarino, 2019, Alimentary pharmacology & therapeutics.

J. Chmiel, A. Moorman, K. Wood, 2004, AIDS patient care and STDs.

Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States

A. Moorman, S. Holmberg, J. Boscarino, 2017, Journal of clinical gastroenterology.

Changing Conditions and Therapies of Ambulatory HIV-Infected Patients: The HIV Outpatient Study (HOPS)

D. Ward, A. Moorman, S. Holmberg, 1999 .

Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection.

A. Moorman, S. Holmberg, J. Boscarino, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Adolescent with COVID-19 as the Source of an Outbreak at a 3-Week Family Gathering — Four States, June–July 2020

C. Szablewski, C. Drenzek, J. Tate, 2020, MMWR. Morbidity and mortality weekly report.

Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.

A. Moorman, S. Holmberg, J. Xing, 2018, Gastroenterology.

Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution

Mei Lu, Anne C. Moorman, Yuna Zhong, 2017, Digestive Diseases and Sciences.

Trends in rates of myocardial infarction among patients with HIV.

A. Moorman, S. Holmberg, A. Greenberg, 2004, The New England journal of medicine.

HIV Genotypic Resistance Testing to Optimize Antiretroviral Prescribing: Is There Room for Improvement?

John T Brooks, Richard Novak, A. Moorman, 2007, Antiviral therapy.

The Use of the International Classification of Diseases, Ninth Revision (ICD-9) Coding in Identifying Chronic Hepatitis B Virus Infection in Health System Data: Implications for Surveillance

A. Moorman, M. Klevens, Reena Mahajan, 2013, Online Journal of Public Health Informatics.

Does Hepatitis C eradication lead to improved glucose metabolism, renal and cardiovascular outcomes in diabetic patients?

A. Moorman, S. Holmberg, J. Boscarino, 2017 .

Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B

A. Moorman, S. Holmberg, J. Boscarino, 2017, Journal of gastroenterology and hepatology.

Underreporting of Hepatitis B and C virus infections — Pennsylvania, 2001–2015

Sameh W. Boktor, A. Moorman, J. Boscarino, 2019, PloS one.

Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.

A. Moorman, S. Holmberg, F. Palella, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Changing trends in complications of chronic hepatitis C

A. Moorman, S. Holmberg, J. Boscarino, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual Epidemics.

A. Moorman, E. Teshale, Neil Gupta, 2023, Public health reports.

Prevention and Care Opportunities for People Who Inject Drugs in an HIV Outbreak — Kanawha County, West Virginia, 2019–2021

A. Moorman, Danae Bixler, A. Hudson, 2022, Journal of General Internal Medicine.

Hepatitis C virus infection preceding an outbreak of HIV among persons who inject drugs- Kanawha County, West Virginia, 2019-2021.

A. Moorman, Danae Bixler, A. Hudson, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Donor-derived Transmission of Hepatitis A Virus Following Kidney Transplantation: Clinical Course of Two Cases From One Donor

A. Moorman, S. Ramachandran, C. Sifri, 2023, Transplantation direct.

The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health Records.

Yuna Zhong, A. Moorman, S. Holmberg, 2017, Population health management.

Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.

A. Moorman, S. Holmberg, J. Boscarino, 2015, The American journal of gastroenterology.

Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention

A. Moorman, S. Holmberg, J. Xing, 2015, Hepatology.

Sustained virological response does not improve long‐term glycaemic control in patients with type 2 diabetes and chronic hepatitis C

A. Moorman, S. Holmberg, J. Boscarino, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study

A. Moorman, S. Holmberg, J. Boscarino, 2015, The American Journal of Gastroenterology.

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)‐exposed and TDF‐unexposed HIV‐infected out‐patients receiving highly active antiretroviral therapy

K. Buchacz, A. Moorman, R. Baker, 2006, HIV medicine.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

K. Buchacz, A. Moorman, J. Brooks, 2011, Journal of viral hepatitis.

Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patients

G. L’italien, U. Iloeje, A. Moorman, 2005, HIV medicine.